Publications by authors named "Salvatore Curatolo"
Two birds one stone: semaglutide is highly effective against severe psoriasis in a type 2 diabetic patient.
Endocrinol Diabetes Metab Case Rep
August 2021
Article Synopsis
- Semaglutide, a GLP-1 receptor agonist, is used for treating type 2 diabetes and has additional benefits like reducing inflammation and regulating the immune system.
- A 73-year-old man with severe obesity and uncontrolled type 2 diabetes, as well as resistant plaque psoriasis, was treated with Semaglutide alongside metformin, leading to improvements in both his diabetes and skin condition.
- Over 10 months, his hemoglobin A1c, body mass index, and psoriasis severity significantly decreased, showcasing the potential for Semaglutide to help patients with difficult-to-treat plaque psoriasis.
Psoriatic arthritis (PsA) patients are often treated by dermatology and rheumatology specialities and may receive different treatments. To evaluate the impact of dermatology/rheumatology specialist settings on diagnosis and therapeutic approach in PsA patients. This cross-sectional multicounty study in Italy involved twenty-eight rheumatology or dermatology clinics.
View Article and Find Full Text PDFPsoriasis is a common cutaneous disorder characterized by abnormal epidermal differentiation, proliferation and inflammation mediated by dermal infiltrates, such as T cells, neutrophils, dendritic cells and macrophages. There are renewed interest in the role of components of the innate immune system. Cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-6, and -1beta involved in pathogenic phenomena in psoriasis are known as inducers of the acute phase response.
View Article and Find Full Text PDF